Bioengineered
Volume 13, 2022 - Issue 6
Open access
2,388
Views
0
CrossRef citations to date
0
Altmetric
Review
Efficacy and safety of mycophenolate mofetil in the treatment of moderate to severe Graves’ orbitopathy: a meta-analysis
Wenwen Fenga Department of Endocrinology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaView further author information
, Yifang Hua Department of Endocrinology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China;b Department of Geriatric Endocrinology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaView further author information
, Chengzhou Zhanga Department of Endocrinology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China;c Department of Internal Medicine, Maternal and Child Health Hospital of Yancheng, Yancheng, ChinaView further author information
, He Shid Department of Nuclear Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaView further author information
, Peng Zhange Department of Ophthalmology, Ili & Jiangsu Joint Institute of Health, the Friendship Hospital of Ili Kazakh Autonomous Prefecture, Ili, ChinaView further author information
, Yanli Yanga Department of Endocrinology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaView further author information
, Shiying Chena Department of Endocrinology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaView further author information
, Weijiang Cuie Department of Ophthalmology, Ili & Jiangsu Joint Institute of Health, the Friendship Hospital of Ili Kazakh Autonomous Prefecture, Ili, ChinaCorrespondence[email protected] [email protected]
View further author information
& View further author information
Dai Cuia Department of Endocrinology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China
https://orcid.org/0000-0001-5534-9558View further author information
Pages 14719-14729
|
Received 17 May 2022, Accepted 09 Jul 2022, Published online: 12 Aug 2022
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.